Advertisement

Agents and Actions

, Volume 18, Issue 5–6, pp 468–472 | Cite as

Indomethacin inhibits the increased airway responsiveness to histamine following inhalation of C5a des Arg in rabbits

  • N. Berend
  • C. L. Armour
  • J. L. Black
Histamine and Kinins

Abstract

It has been shown that inhalation of C5a des Arg increases rabbit airway responsiveness to histamine and that this is associated with an influx of neutrophils into the airway walls. This study was undertaken to see if the augmented response to histamine can be blocked by the cyclo-oxygenase inhibitor indomethacin. Spontaneously breathing, anesthetised rabbits were studied in a volume displacement plethysmograph and pulmonary resistance (R1) was measured using the electrical subtraction technique. Histamine dose response curves (HDR) were generated by measuring R1 after serial nubulisation of saline and histamine (1, 3, 10, 30 and 100 mg/ml). Aerosols of either saline or C5a des Arg (1.5 ug/ml) were then inhaled by the animals over a time period of 2 min. An HDR was then repeated 4 hours later. In 9 rabbits the inhalation of C5a des Arg resulted in an upward shift of the repeat HDR: the area under the HDR was significantly greater than under the first HDR (p<0.05). In 6 rabbits the repeat HDR 4 hours after saline was shifted downwards (N.S.) indicating some degree of tachyphylaxis. When rabbits were pretreated with indomethacin (5 mg/kg i.v.) the repeat HDR following either C5a des Arg (n=7) or saline (n=6) were also shifted downwards i.e., the increased airway responsiveness noted after C5a des Arg was abolished. There was no significant difference in baseline saline R1 during the first or second HDR in any group. These results suggest that the increased airway responsiveness following nebulisation of C5a des Arg may be due to release from neutrophils of products of the cyclo-oxygenase pathway.

Keywords

Histamine Indomethacin Response Curve Dose Response Curve Airway Responsiveness 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. [1]
    J.W. Gerrard, D.W. Cockroft andJ.A. Dosman,Increased non-specific bronchial reactivity in cigarette smokers with normal lung function, Am. Rev. Respir. Dis.122, 577–581 (1980).PubMedGoogle Scholar
  2. [2]
    J. Bahous, A. Cartier, B. Ouimet, L. Pineau andJ.L. Malo,Nonallergic bronchial hyperexcitability in chronic bronchitis, Am. Rev. Respir. Dis.129, 21–220 (1984).Google Scholar
  3. [3]
    W.C. Hulbert, D.C. Walker, A. Jackson andJ.C. Hogg,Airway permeability to horseradish peroxidase in guinea pigs: the repair phase after injury by cigarette smoke, Am. Rev. Respir. Dis.123, 320–326 (1981).PubMedGoogle Scholar
  4. [4]
    D.W. Empey, L.A. Laitinen, L. Jacobs, W.M. Gold andJ.A. Nadel,Mechanism of bronchial hyperreactivity in normal subjects after upper respiratory tract infection, Am. Rev. Respir. Dis.113, 31–139 (1976).PubMedGoogle Scholar
  5. [5]
    J.J. Walsh, L.F. Dietlein, F.N. Low, G.E. Burch andW.J. Mogabgab,Bronchotracheal response in human influenza, Arch. Int. Med.108, 98–110 (1961).Google Scholar
  6. [6]
    D.W. Cockroft, R.E. Ruffin, J. Dolovich andF.E. Hargreave,Allergen-induced increase in non-allergic bronchial reactivity, Clin. Allergy7, 503–573 (1977).PubMedGoogle Scholar
  7. [7]
    A. Cartier, N.C. Thomson, P.A. Frith, R. Roberts andF.E. Hargreave,Allergen-induced increase in bronchial responsiveness to histamine: relationship to the late asthmatic response and change in airway calibre, J. Allergy Clin. Immunol.70, 170–177 (1982).PubMedGoogle Scholar
  8. [8]
    J.A. Golden, J.A. Nadel andH.A. Boushey,Bronchial hyperirritability in healthy subjects after exposure to ozone, Am. Rev. Respir. Dis.18, 287–294 (1978).Google Scholar
  9. [9]
    M.J. Holtzman, L.M. Fabbri, P.M. O'Byrne, B.D. Gold, H. Aizawa, E.H. Walters, S.E. Alpert andJ.A. Nadel,Importance of airway inflammation for hyperresponsiveness induced by ozone, Am. Rev. Respir. Dis.127, 686–690 (1983).PubMedGoogle Scholar
  10. [10]
    P.M. O'Byrne, E.H. Walters, B.D. Gold, H.A. Aizawa, L.M. Fabbri, S.E. Alpert, J.A. Nadel andM.J. Holtzman,Neutrophil depletion inhibits airway hyperresponsiveness induced by ozone exposure, Am. Rev. Respir. Dis.13, 214–219 (1984).Google Scholar
  11. [11]
    C.G. Irvin, P.M. Henson andN. Berend,Acute effects of airways inflammation on airway function and reactivity, Fed. Proc.41, 1358 (1982).Google Scholar
  12. [12]
    P.M. O'Byrne, E.H. Walters, H. Aizawa, L.M. Fabbri, M.J. Holtzman andJ.A. Nadel,Indomethacin inhibits the airway hyperresponsiveness but not the neutrophil influx induced by ozone in dogs, Am. Rev. Respir. Dis.130, 20–224 (1984).Google Scholar
  13. [13]
    J. Mead andJ.L. Whittenberg,Clinical measurement of resistive and elastic properties of the lungs, J. Clin. Invest.32, 588–589 (1953).Google Scholar
  14. [14]
    P.J. Jose, M.J. Forrest andT.J. Williams,Human C 5 a des Arg increases vascular permeability, J. Immunol.127, 2376–2380 (1981).PubMedGoogle Scholar
  15. [15]
    J.R. Tallarida andL.S. Jacob,Dose response relation in pharmacology, New York, Springer Verlag (1979).Google Scholar
  16. [16]
    S.F. Quan, M.L. Witten, R.J. Lemen, J.C. Stevenson andH.R. Rosebery,Between and within animal variability of aerosolised histamine in normal rabbits, Am. Rev. Respir. Dis. 129S, A278 (1984).Google Scholar
  17. [17]
    R.C. Boucher, P.D. Pare andJ.C. Hogg,Relationship between airway hyperreactivity and hyperpermeability in Ascaris-sensitive monkeys, J. Allergy Clin. Immunol.64, 197–201 (1979).PubMedGoogle Scholar
  18. [18]
    R.C. Boucher, J. Johnson, S. Inoue, W. Hulbert andJ.C. Hogg,The effect of cigarette smoke on the permeability of guinea pig airways, Lab. Invest.13, 94–100 (1980).Google Scholar
  19. [19]
    A.A. Hutchison, J.M. Hinson, K.C. Brigham andJ.R. Snapper,Effect of endotoxin on airway responsiveness to aerosol histamine in sheep, J. Appl. Physiol.54, 1463–1468 (1983).PubMedGoogle Scholar
  20. [20]
    L.M. Fabbri, H. Aizawa, S.E. Alpert, E.H. Walters, P.M. O'Byrne, B.D. Gold, J.A. Nadel andM.J. Holtzman,Airway hyperresponsiveness and changes in cell counts in broncho-alveolar lavage after ozone exposure in dogs, Am. Rev. Respir. Dis.129, 288–291 (1984).PubMedGoogle Scholar
  21. [21]
    J.M. Hinson, A.A. Hutchison, K.L. Brigham, B.O. Neyrick andJ.R. Snapper,Effects of granulocyte depletion on pulmonary responsiveness to aerosol histamine, J. Appl. Physiol.56, 411–417 (1984).PubMedGoogle Scholar
  22. [22]
    G. Weissman, J.E. Smolen andH.M. Korchak,Release of inflammatory mediators from stimulated neutrophils, N. Engl. J. Med.303, 27–34 (1980).PubMedGoogle Scholar
  23. [23]
    A.W. Ford-Hutchinson, M.A. Bray, M.V. Doig, M.E. Shipley andM.J.H. Smith,Leukotriene B. A potent chemokinetic and aggregating substance released from polymorphonuclear leucocytes, Nature286, 264–265 (1980).CrossRefPubMedGoogle Scholar
  24. [24]
    J.M. Lynch, G.Z. Lotner, S.J. Betz andP.M. Hinson,The release of platelet activity factor by stimulated rabbit neutrophils, J. Immunol.123, 1219–1226 (1979).PubMedGoogle Scholar
  25. [25]
    P.O. Clark, D.J. Hanahan andR.N. Pinkard,Physical and chemical properties of platelet activating factor (PAF) obtained from human neutrophils and monocytes and rabbit neutrophils and basophils, Biochem. Biophys. Acta.62, 69–75 (1980).Google Scholar
  26. [26]
    E.H. Walters, R.W. Parrish, C. Bevan andA.P. Smith,Induction of bronchial hypersensitivity: evidence for a role for prostaglandins, Thorax36, 571–574 (1981).PubMedGoogle Scholar
  27. [27]
    E.H. Walters,Prostaglandins and the control of airway responses to histamine in normal and asthmatic subjects, Thorax38, 188–194 (1983).PubMedGoogle Scholar
  28. [28]
    E.H. Walters,Effect of inhibitors of prostaglandin synthesis on induced bronchial hyperresponsiveness, Thorax38, 195–199 (1983).PubMedGoogle Scholar
  29. [29]
    G. Folkerts, F.P. Nijkamp andJ.M. van Oosterhout,Induction in guinea pigs of airway hyperreactivity and decreased lung adrenoceptor number by 15-hydroperoxy-arachidonic acid, Br. J. Pharmac.80, 597–599 (1983).Google Scholar
  30. [30]
    B.B. Vargaftig, J. Lefort, M. Chignard andJ. Benveniste,Platelet activating factor induces a platelet-dependent broncho-constriction unrelated to the formation of prostaglandin derivatives, Eur. J. Pharmacol.65, 185–192 (1980).CrossRefPubMedGoogle Scholar
  31. [31]
    Y. Hamasaki, M. Morjarad, T. Saga, H.H. Tai andS.I. Said,Platelet-activating factor varies airway and vascular pressures and induces edema in lung perfused with platelet-free solution, Am. Rev. Respir. Dis.12, 742–746 (1984).Google Scholar
  32. [32]
    C.G. Irvin, G. Baltopoulos andP. Henson,Airways hyperreactivity produced by products from phagocytosing neutrophils, Am. Rev. Resp. Dis. 131S, A278 (1985).Google Scholar
  33. [33]
    R.W. Randall, K.E. Eakins, G.A. Higgs, J.A. Salmon andJ.E. Taterson,Inhibition of arachidonic acid cyclo-oxygenase and lipoxygenase activities of leukocytes by indomethain and compound BW 755C, Agents Actions10, 553–555 (1980).PubMedGoogle Scholar
  34. [34]
    M.I. Siegel, P. McConnell andP. Cuatrecasos,Aspirin-like drugs interfere with arachidonate metabolism by inhibition of the 12-hydroperoxy-5, 8, 10, 14-eicosatetranoic acid peroxidase activity of the lipoxygenase pathway, Proc. Natl. Acad. Sci. USA76, 3774–3778 (1979).PubMedGoogle Scholar
  35. [35]
    T.H. Lee, T. Nagakura, O. Cromwell, M.J. Brown, R. Causon andA.B. Kay,Neutrophil chemotactic activity and histamine in atopic and non-atopic subjects after exercise-induced asthma, Am. Rev. Respir. Dis.129, 409–412 (1984).PubMedGoogle Scholar
  36. [36]
    P.C. Atkins, M. Norman, H. Weinen andB. Zweiman,Release of neutrophil chemotactic activity during immediate hypersensitivity reaction in humans, Ann. Int. Med.86, 416–618 (1977).Google Scholar

Copyright information

© Birkhäuser Verlag 1986

Authors and Affiliations

  • N. Berend
    • 1
  • C. L. Armour
    • 1
  • J. L. Black
    • 1
  1. 1.The Departments of Medicine and PharmacologyUniversity of SydneyAustralia

Personalised recommendations